Jon Congleton

Insider Reports History

Entity
Individual
Location
3122 Sterling Circle, Suite 200, Boulder, CO
Signature
/s/ Adam Levy, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jon Congleton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. Chief Executive Officer, Director Common Stock 911K $12.2M $13.34 Jul 11, 2024 Direct
Mineralys Therapeutics, Inc. Chief Executive Officer, Director Stock Option 425K Feb 13, 2024 Direct

Insider Reports Filed by Jon Congleton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MLYS Mineralys Therapeutics, Inc. Jul 11, 2024 1 -$210K 4 Jul 12, 2024 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Jun 17, 2024 3 -$592K 4 Jun 20, 2024 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Jun 12, 2024 3 -$924K 4 Jun 14, 2024 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Nov 22, 2023 1 $25.4K 4 Nov 27, 2023 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Sep 6, 2023 1 $27.2K 4 Sep 8, 2023 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Aug 17, 2023 1 $27.2K 4 Aug 21, 2023 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Aug 11, 2023 1 $25.8K 4 Aug 11, 2023 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Mar 17, 2023 1 $0 4 Mar 21, 2023 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Chief Executive Officer, Director
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 0 $0 3 Feb 9, 2023 Chief Executive Officer, Director